Skip to Main Content

Paper Details

ALK Inhibitor Treatment Patterns and Outcomes in Real-World Patients with ALK-Positive Non-Small-Cell Lung Cancer: A Retrospective Cohort Study.
Target Oncol
1
2023
Author NameAffiliation
Atul J ButteBakar Computational Health Sciences Institute, University of California San Francisco
Atul J ButteUniversity of California San Francisco
Vivek A RudrapatnaBakar Computational Health Sciences Institute, University of California San Francisco
Vivek A RudrapatnaUniversity of California San Francisco
  • 1 - 4

Datasets